Reply to: "Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there

Bernhard Scheiner1, Matthias Pinter1

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Liver Cancer (HCC) Study Group Vienna, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Journal of Hepatology
|January 3, 2022
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos